Rachel Yost

Rachel Yost is an Associate Director, MSAT at GentiBio. Prior to joining GentiBio, Rachel worked at Juno Therapeutics / Bristol Myers Squibb, playing a significant role in Global Manufacturing, Science & Technology (MSAT) throughout the lifecycle of the Breyanzi CAR-T cell therapy product. Most recently Rachel lead the MSAT Early Phase Drug Product Stewardship team supporting multiple pipeline cell therapy programs. Rachel was previously a process engineer at Merck in Durham, NC. Rachel received her BS in Bioengineering from Penn State.